The explosion of new trial data over the last few years has created a knowledge gap for many physicians as it is almost impossible to stay abreast of many treatment modalities. Updating our audience on the AFib Guidelines and many trials such as ATHENA, RE-LY, DIONYSOS, MADIT and the ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities, will support our education program's goals.
The leading cause of death in adults in the United States is sudden cardiac death. In atrial fibrillation, new drugs have been developed to maintain sinus rhythm and prevent stroke. Intracardiac catheter ablation techniques have advanced to the point that they are often first-line therapy for many arrhythmias. Implantable defibrillators save lives as has been demonstrated in multiple randomized clinical trials.
Simultaneous pacing of the right and left ventricles, cardiac resynchronization therapy, can dramatically alleviate symptoms and prevent hospitalization and reduce hospital readmission rates for large sub groups of HF patients. It is an exciting new area of research with new data to support remarkable alleviation of heart failure symptoms in selected patients.
The advances in diagnostic and therapeutic methods for patients with cardiac arrhythmias, as well as the intersection of heart failure and arrhythmias, allows an opportune time for our Foundation to present a symposium dedicated to the management of various patient groups with cardiac arrhythmias. The Foundation has been committed to education on all levels from our training program for fellows to referring physicians, and other health care professionals.
Physicians (IM, FP, GP), cardiologists, heart failure specialists, electrophysiologists, pulmonologists, ER physicians, nurse practitioners, registered nurses and allied health professionals.
Morning and afternoon didactic with interactive panel discussion and case studies.
Audience will fill out course evaluation which will be tallied and reviewed for future symposiums.
